Cargando…
Carvedilol versus Metoprolol in Patients with Ventricular Tachyarrhythmias
The study investigates the prognostic role of treatment with carvedilol as compared to metoprolol in patients with ventricular tachyarrhythmias. A large retrospective registry was used including consecutive patients on beta-blocker (BB) treatment with episodes of ventricular tachycardia (VT) or fibr...
Autores principales: | Schupp, Tobias, Behnes, Michael, Abumayyaleh, Mohammad, Weidner, Kathrin, Rusnak, Jonas, Mashayekhi, Kambis, Bertsch, Thomas, Akin, Ibrahim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410246/ https://www.ncbi.nlm.nih.gov/pubmed/36005438 http://dx.doi.org/10.3390/jcdd9080274 |
Ejemplares similares
-
Angiotensin Converting Enzyme Inhibitors versus Receptor Blockers in Patients with Ventricular Tachyarrhythmias
por: Schupp, Tobias, et al.
Publicado: (2022) -
Prognostic Impact of Different Types of Ventricular Tachyarrhythmias Stratified by Underlying Cardiac Disease
por: Schupp, Tobias, et al.
Publicado: (2022) -
Prognostic Value of Cardiac Troponin I in Patients with Ventricular Tachyarrhythmias
por: Akin, Ibrahim, et al.
Publicado: (2022) -
Prognostic value of beta-blocker doses in patients with ventricular tachyarrhythmias
por: Schupp, Tobias, et al.
Publicado: (2022) -
Type 2 diabetes is independently associated with all-cause mortality secondary to ventricular tachyarrhythmias
por: Weidner, Kathrin, et al.
Publicado: (2018)